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Abstract
Thyroid nodules are a common occurrence in the general pop-
ulation, and these incidental thyroid nodules are often referred
for ultrasound (US) evaluation. US provides a safe and fast
method of examination. It is sensitive for the detection of
thyroid nodules, and suspicious features can be used to guide
further investigation/management decisions. However, given
the financial burden on the health service and unnecessary
anxiety for patients, it is unrealistic to biopsy every thyroid
nodule to confirm diagnosis. The British Thyroid Association
(BTA) has recently produced a US classification (U1–U5) of
thyroid nodules to facilitate the decision-making process re-
garding the need to perform fine-needle aspiration cytology
(FNAC) for suspicious cases. In this pictorial review, we pro-
vide a complete series of sonographic images to illustrate be-
nign and malignant features of thyroid nodules according to
the U1–5 classification. Specifically, we highlight morpholog-
ic characteristic of the nodule, including its echo signal in
relation to its consistency, nodular size, number and contour.
Additional diagnostic features such as halo, colloid, calcifica-
tion and vascular patterns are also discussed in detail. The aim
is to assist radiologists and clinicians in recognising
sonographic patterns of benign, suspicious and malignant
nodules based on U1–5 criteria, and in planning for further
investigations.
Main messages
• Ultrasound is sensitive in identifying suspicious features,
which require aspiration.
• Whether nodules require aspiration should be based on
sonographic features and clinical findings.
• U1–5 classification of sonographic findings can help deter-
mine whether aspiration is necessary.
Keywords Thyroid nodule . Thyroid cancer . Ultrasound .
Fine-needle aspiration . Sonographic features
Introduction
A thyroid nodule is a discrete lesionwithin the normal thyroid.
Such nodules are a common occurrence in the general popu-
lation and a frequent incidental finding on computed tomog-
raphy (CT) and magnetic resonance imaging (MRI). Autopsy
studies have reported incidental thyroid nodules in up to 50%
of subjects [1]. Most nodules are benign, but between 3 and
7% of cases are found to be malignant [2]. Ultrasound (US)
has become an important diagnostic tool in the assessment of
thyroid nodules. It is highly sensitive for detecting nodules,
and the sonographic features of the nodules can be used to
determine the need for further investigation [3]. A number of
studies have investigated both benign and malignant sono-
graphic features of thyroid nodules [1, 4–7]. However, be-
cause it is unrealistic from an economic and patient anxiety
point of view to biopsy every thyroid nodule in order to ex-
clude malignancy, a reliable guideline was necessary to spe-
cifically target nodules that require biopsy. Based on current
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evidence, the British Thyroid Association (BTA) recently pro-
duced a US classification (U1–U5) of thyroid nodules to fa-
cilitate the decision-making process regarding the need to per-
form fine-needle aspiration cytology (FNAC) in suspicious/
unequivocal cases [8]. The aim of this pictorial review is to
present detailed sonographic images that correspond to each
feature as described in the BTA guideline in order to help
radiologists and clinicians readily recognise the sonographic
patterns and classify nodules into categories of U1 to U5
(Figs. 1, 2, 3, 4, and 5).
Ultrasound classification (U1): the normal thyroid
US is a safe, fast and comfortable method for evaluating the
thyroid gland and regional anatomy. A high-resolution probe
between 10 and 15 MHz should be used to examine the neck.
The patient should be lying supine and the neck in a slightly
hyper-extended position to fully expose the anterior neck. A
semi-erect position is acceptable if the patient is unable to
tolerate the preferred posture. Before anyone can become ad-
ept in identifying abnormalities, it is critical to become famil-
iar with the normal sonographic appearance of the thyroid
gland relative to surrounding structures.
The normal thyroid gland is homogenous and is mild-
ly hyper-echogenic compared to surrounding muscles
(Fig. 1). Each lobe of the thyroid has a globular shape
with a smooth outline. Individual lobes and any suspi-
cious structure must be examined in both the axial and
longitudinal views. The isthmus is located at the anterior
aspect between the lobes and anterior to the trachea. Two
important features make the trachea readily identifiable:
the trachea has no US signal, as it is filled with air,
which does not transmit US, and the cartilaginous rings
at the anterior aspect of the trachea produce curvilinear
hyper-echogenic signals. The carotid arteries are round
hypo-echogenic tubular structures located laterally to
each lobe of the thyroid. Further lateral to the carotid
arteries is the paired internal jugular vein, which is often
collapsed but can be distended with the Valsalva ma-
noeuvre to aid in identification. Apart from these two
large vessels, there are often echo-free thinner vessels
travelling within and around the periphery of the thyroid
gland. All vascular structures should be closely interro-
gated with colour or power Doppler imaging. Firstly, this
is a useful technique for separating blood vessels from
cystic structures. Secondly, the vascular pattern at and
around a thyroid nodule is a useful feature in differenti-
ating between benign and malignant lesions. The
BTA U-
classification




a. Axial view of right thyroid lobe (Th). Isthmus
(Is) is anterior to the trachea (Tra). The carotid
artery (C) is round and hypo-echogenic located 
laterally to the thyroid. Internal jugular vein (J) is 
lateral to the carotid artery. Strap muscle (SM) and
sternocleidomastoid muscle (SCM) wrap around 
the anterior aspect of the thyroid.        
b. Longitudinal view of the right thyroid lobe.  
Not required*
Fig. 1 (a) Axial view of right thyroid lobe (Th). Isthmus (Is) is anterior to
the trachea (Tra). The carotid artery (C) is round and hypo-echogenic
located laterally to the thyroid. The internal jugular vein (J) is lateral to
the carotid artery. The strap muscle (SM) and sternocleidomastoid muscle
(SCM) wrap around the anterior aspect of the thyroid. (b) Longitudinal
view of the right thyroid lobe
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U2 (c) – Benign: 
Micro-cystic / 
spongiform
c. A benign nodule with hypo-echoic  
cystic spaces resulting in a spongiform or 
honeycomb appearance.
Not required*




d. A benign nodule with eggshell calcification.
Note the acoustic shadowing produced by the
calcific ring.   
e. A benign nodule with eggshell  
calcification.
Not required*
U2 (f) – Benign: 
Peripheral 
vascularity
f. A benign nodule with peripheral   
vascularity on doppler assessment.
Not required*
U2 (a) – Benign: 
halo, iso-echoic / 
mildly hyper-
echoic
a. A benign nodule. It is iso-echoic relative to the
 thyroid, and surrounded by a hypoechogenic halo.  
Not required*
U2 (b) – Benign: 
cystic change +/-
ring down sign 
(colloid)
b. A benign cystic nodule with multiple colloids,  





Thyroid ultrasound & description Fine needle 
aspiration cytology 
(FNAC)
Fig. 2 (a) A benign nodule. It is iso-echoic relative to the thyroid,
and surrounded by a hypo-echogenic halo. (b) A benign cystic
nodule with multiple colloids, which are seen as hyper-echoic
spots with comet-tail. (c) A benign nodule with hypo-echoic cystic
spaces resulting in a spongiform or honeycomb appearance. (d) A
benign nodule with eggshell calcification. Note the acoustic
shadowing produced by the calcific ring. (e) A benign nodule with
eggshell calcification. (f) A benign nodule with peripheral vascu-
larity on Doppler assessment
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muscular structures (strap muscle and sternocleidomastoid
muscle) wrap around the anterior aspect of the thyroid gland
and have lower echo signal relative to the thyroid. Other com-
monly identifiable regional structures include the lymph
nodes, nerves and the oesophagus, which is situated
posteromedially to the left lobe of the thyroid. The parathyroid
glands are rarely seen unless there is enlargement of
the glands.
For anyone performing US examination of the neck, a
sound knowledge of the normal anatomy and a systemic scan-
ning approach are prerequisites for confidently identifying
and fully characterising thyroid nodules.
Ultrasound classification (U2): benign thyroid
nodule
OnUS, thyroid nodules are depicted as discrete lesions, as they
cause distortion of the homogeneous echo pattern of the thy-
roid gland [9]. There are various characteristics onUS that help
to distinguish benign from malignant nodules. However, it is
important to emphasise that the size and number of nodules are
not reliable factors for disease differentiation. Evidence has
shown that nodular size is not predictive of malignancy risk,
and that nodular morphology, rather, is the more important








a. A markedly hyper-echogenic nodule is 
considered indeterminate regarding its malignant 








b. A nodule containing an echogenic focus that 





c. Doppler assessment of a nodule showing mixed
vascularity, which consists of both peripheral and




Thyroid ultrasound & description Fine needle 
aspiration cytology 
(FNAC)
Fig. 3 (a) A markedly hyper-echogenic nodule is considered indetermi-
nate regarding its risk of malignancy. (b) A nodule containing an
echogenic focus that appears to be cystic is indeterminate. (c) Doppler
assessment of a nodule showingmixed vascularity, which consists of both
peripheral and intra-nodular vasculature
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not associated with higher risk of cancer. Regardless of nodule
quantity, the overall incidence of thyroid cancer is shown to be
consistently between 9.2 and 13% after FNAC [1, 5, 14].
The following morphologic characteristics are suggestive
of a benign thyroid nodule. For signal intensity, the nodule
should have the same echo signal or be slightly hyper-
echogenic relative to the surrounding normal thyroid tissue.
This solid nodule may be accompanied by a hypo-echogenic
halo (Fig. 2a), which represents fibrous connective tissue,
compressed thyroid tissue and vessels [8]. In cases where
the nodule appears cystic, it should contain colloids, which
appear as a hyper-echogenic spot with ‘comet-tail’ shadowing
or a ‘ring-down’ sign (Fig. 2b) [8]. In addition, some nodules
can have a spongiform/honeycomb consistency with dark
micro-cystic spaces (Fig. 2c). The spongiform appearance
has been shown to have specificity of 99.7% for benign dis-
ease and 98.5% negative predictive value for malignancy [7,
9]. At the peripheries of the nodule, complete eggshell-type
calcification (Fig. 2d and e) [15, 16] and peripheral vascularity
on Doppler assessment (Fig. 2f) are also reassuring signs [7,
signal lower than the surrounding thyroid tissue 





b. A suspicious hypo-echoic nodule with signal 








c. A suspicious hypo-echoic nodule with 






d. A suspicious hypo-echoic nodule with a lobular










Thyroid ultrasound & description Fine needle 
aspiration cytology 
(FNAC)
Fig. 4 (a) A suspicious hypo-
echoic nodule with signal lower
than the surrounding thyroid tis-
sue but higher than the strap
muscle above. (b) A suspicious
hypo-echoic nodule with signal
lower than both thyroid tissue and
strap muscle. (c) A suspicious
hypo-echoic nodule with
interrupted eggshell calcification
around the edges. (d) A suspi-
cious hypo-echoic nodule with a
lobular margin
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hyper-echoic foci of calcification and an irregular 











b. This hypo-echoic nodule has a single coarse
globular calcification and an irregular contour.





c. Thyroid nodule with intra-nodular vascularity.





d. A hypo-echoic nodule that is taller than wide 














Thyroid ultrasound & description Fine needle 
aspiration cytology 
(FNAC)
Fig. 5 (a) This hypo-echoic nodule has small hyper-echoic foci of cal-
cification and an irregular lobulated contour. FNAC confirmed papillary
thyroid cancer. (b) This hypo-echoic nodule has a single coarse globular
calcification and an irregular contour. FNAC confirmed medullary thy-
roid cancer. (c) Thyroid nodule with intra-nodular vascularity, later
confirmed to be papillary thyroid cancer. (d) A hypo-echoic nodule that
is taller than wide is considered to be malignant. (e) An abnormal lymph
node with malignant features—irregular contours, mixed echotexture and
vascularity. An abnormal lymph node would result in a U5 category
despite any benign features of the thyroid nodule
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17]. A thyroid nodule with these features would be a benign
nodule and does not require FNAC. If the patient is asymp-
tomatic and there is no clinical suspicion or risk factors for
malignancy, further US follow-up is not recommended by the
BTA [8]. Clinical and risk factors that should be considered
include [8, 18]:
& Age <20 or > 60 years
& The nodule is firm on palpation
& A history of fast-growing nodule
& Vocal cord paralysis, which should be further investigated
& Regional lymphadenopathy
& Previous radiotherapy to the neck region
& Family history of thyroid cancer
Patients presenting for US assessment of a possible thy-
roid nodule usually involve cases of an incidental nodule
found on other imaging investigations or general practi-
tioner (GP) referrals for a palpable thyroid lump. The ma-
jority of nodules will be benign [19], and evidence indi-
cates that incidental nodules, palpable and non-palpable
nodules have the same incidence of thyroid cancer [4,
20]. The incidence of thyroid cancer is on the rise, but
early detection has not led to any changes in mortality.
Studies suggest that the high sensitivity of US has been
responsible for the detection of incidental nodules, which
has resulted in overdiagnosis of these subclinical cases
[21–23]. This evidence supports the opinion that incidental
nodules do not require US assessment unless the patient
also has risk factors and clinical findings that are suspi-
cious for malignancy [14, 19, 24].
Ultrasound classification (U3): indeterminate/
equivocal
On assessment of the thyroid nodule, there are situations in
which, among a collection of benign sonographic appear-
ances, there are certain features that place doubt on the diag-
nosis. Occasionally, the nodule may be markedly hyper-
echogenic (Fig. 3a), or part of the nodule may appear cystic
and contain echogenic foci (Fig. 3b). Further Doppler assess-
ment of the nodule may demonstrate a mixture of both periph-
eral and intra-nodular vascularity (Fig. 3c). These sonographic
features are classified as indeterminate. FNAC should be per-
formed, taking into consideration the clinical information [8].
Ultrasound classification (U4): suspicious thyroid
nodule
Thyroid nodules in this category are considered to be suspi-
cious for malignancy, and all these nodules should be further
investigated with FNAC [8]. The first distinctive feature of
these suspicious nodules is their hypo-echogenicity [8]. The
echo signals of the nodule or part of the nodule are less than
the surrounding normal thyroid tissue (Fig. 4a) and sometimes
lower than the nearby muscle (Fig. 4b). It is important to note
that these nodules are hypo-echogenic, but they are also pre-
dominantly solid in consistency. This property makes their
echo signals higher than those of a cystic nodule, which is
dark and echo-free. On a spectrum from highest to lowest
likelihood of malignancy, predominantly solid nodules have







*Benign U1 and U2 thyroid nodules do not require fine needle aspiration cytology 
(FNAC) unless the patient is considered to be high risk. 
Fig. 5 (continued)
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cystic or spongiform have the lowest risk [1]. Furthermore, the
suspicious nodule may have disrupted eggshell calcification
around the peripheries (Fig. 4c) or lost its smooth round con-
tour, and adopted a lobulated margin (Fig. 4d) [8]. A U4
thyroid nodule is hypo-echogenic, with an irregular outline
and possible disrupted calcification at the edges.
Ultrasound classification (U5): malignant thyroid
nodule
When assessing a thyroid nodule, it is important to note that
malignant lesions are rare. The incidence of the disease is 2–4
cases per 100,000 persons per year [25]. The most prevalent
form of thyroid cancer is papillary thyroid cancer (75-80%),
followed by follicular (10-20%), medullary (3-5%) and ana-
plastic (1-2%) thyroid cancers [2, 26]. The survival rate for
thyroid cancer in general is better than for other forms of
cancer. For papillary thyroid cancer, the 20-year survival after
surgery is around 99% [27].
There are a number of features on US that are suggestive of
a malignant thyroid nodule. Such nodules are frequently
hypo-echoic on US relative to the adjacent normal thyroid
tissue [8]. However, this is not diagnostic, and should be con-
sidered with other features indicative of malignancy. On mea-
suring the size of the nodule, it is necessary to assess both the
anteroposterior (AP) and transverse (TR) diameters in the ax-
ial plane.When the AP diameter is more than the TR diameter,
the nodule is described as ‘taller than wide’ in shape, which
increases the risk of malignancy (Fig. 5d) [28]. The additional
presence of hyper-echoic foci of calcifications within the nod-
ule further increases the likelihood of cancer—approximately
three times the cancer risk for micro-calcifications and twice
the risk for coarse calcifications [1]. Micro-calcifications have
been reported to have specificity of 44–95% for thyroid can-
cer, and are particularly associated with papillary thyroid can-
cer (Fig. 5a). However, the sensitivity of micro-calcifications
is low (26–59%) [1, 7, 29, 30]. Coarse macro-calcifications
are not specific for malignancy, as they commonly occur in
multinodular goiters. However, in situations where there is a
single nodule containing coarse calcification, the risk of
cancer can be as high as 75% [31]. Coarse calcification is
often associated with medullary thyroid carcinoma (Fig. 5b).
A malignant nodule can also have an irregular shape with
irregular edges (Fig. 5a). Further evaluation of the nodular
vascularity should be performed with colour or power
Doppler. Malignant lesions tend to demonstrate intra-nodular
vascularity (Fig. 5c). In contrast, benign nodules have a pe-
ripheral rim of blood flow (Fig. 2f) [1]. When both intra-
nodular and peripheral vascularity are present, the nodule is
indeterminate (Fig. 3c). All U5 nodules should be investigated
with FNAC.
It is important to emphasise that no single sonographic
feature should be used to differentiate between benign and
malignant nodules [13]. Instead, the overall appearance and
collective features of the thyroid nodule should be considered
for diagnosis. Figure 6 illustrates a nodule in the left lobe of
the thyroid. It consists of colloids, with their characteristic
‘comet-tail’ shadowing. Colloids, as discussed earlier, are fea-
tures indicative of benign nodules. However, the nodule is
hypo-echoic with an echo signal close to the adjacent strap
muscle. In addition, the posterior aspect of the nodule appears
irregular and lobulated. Power Doppler shows marked intra-
nodular vascularity. For this nodule, there is a benign feature
(colloids), but the series of sinister characteristics of the nod-
ule puts it between the suspicious U4 and malignant U5 cat-
egories, which require FNAC. This case also illustrates that
the presence of malignant features takes precedence over any
benign characteristics of the nodule. The results of FNAC of
this nodule confirmed papillary thyroid cancer.
Lymph node assessment
Lymph node involvement is most common in papillary thy-
roid cancer. In 20% of patients with papillary thyroid cancer, a
symptomatic cervical lymph node is one of the main com-
plaints. In addition, nodal metastases have been reported in
50% of patients with papillary thyroid cancer on first presen-
tation [32]. In follicular thyroid cancer, metastases have a
tendency to spread to distant organs. For medullary thyroid
Fig. 6 The thyroid nodule in the
left lobe consists of colloids with
their characteristic ‘comet-tail’
shadowing (arrows). However, it
is hypo-echoic with an echo sig-
nal close to the adjacent strap
muscle. Power Doppler shows
marked intra-nodular vascularity.
Multiple sinister characteristics of
the nodule put it between U4 and
U5, which require FNAC
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cancer, both cervical lymph nodes and distant organs can be
involved [33].
Cervical lymph node assessment should be an integral part
of the thyroid nodule examination. The neck should be thor-
oughly screened for any abnormal lymph nodes. Normal and
reactive lymph nodes are usually oval with an echogenic hi-
lum, and they are typically hypo-echoic relative to nearby
muscle. On Doppler evaluation, there is normally colour flow
at the hilum of a reactive lymph node, but it can also appear
avascular [34]. An abnormal lymph node would have lost one
or a combination of these normal features in terms of shape,
echotexture, fatty hilum, irregular contour and vascularity
(Fig. 5e). The presence of an abnormal lymph node would
result in a category of U5 regardless of any benign features
of the thyroid nodule. Abnormal lymph nodes should undergo
FNAC along with the nodule to facilitate accurate diagnosis
and staging [8].
A thorough discussion of cervical lymph node evaluation is
beyond the scope of this article. However, a number of studies
have illustrated in detail the sonographic characteristics of
neck lymph nodes [34–37], which the reader should find use-
ful for guiding the ultrasound examination.
Reporting findings
In providing a report after the US examination of the thyroid
nodule, the practitioner should aim to address several factors
regarding the nodule. The report should include a detailed
description of the nodule with regard to its size, location,
composition and echogenicity in relation to surrounding struc-
tures. The nodular margins should be closely examined to
indicate the contour and presence of rim calcification or halo,
and any additional features such as colloid calcification and
vascular pattern. The lymph nodes should also be screened
and commented on if there are any suspicious features.
Based on the collection of sonographic findings, the practi-
tioner should provide a US classification of the thyroid nodule
from U1 to U5. When there are multiple nodules, the most
suspicious nodule should be used for scoring [8]. If FNAC
was performed, this should also be clearly documented on the
report. The clinical team should be informed of the results,
irrespective of benign or malignant disease. A multi-
disciplinary approach is recommended if malignancy is
suspected or when there is discordance between US or
FNAC findings and clinical evidence [8].
The BTA thyroid nodule U-classification is designed to
simplify the process of identifying suspicious and malignant
nodules. Its purpose is to provide guidance on the appropriate
use of FNAC. Benign thyroid conditions, such as thyroiditis,
are not part of the U-classification, and are not included in the
pictorial review. Apart from the BTA U-classification, there
are other recognised guidelines for the management of thyroid
nodules [9, 11, 38]. A comparison of the U-classification with
other guidelines is beyond the scope of this pictorial review,
which serves to illustrate the sonographic features as de-
scribed in the BTA guideline. These are limitations of this
study.
Conclusions
US provides a safe and fast method for the examination of
thyroid nodules. Such nodules are common, however, and it
would be impractical to biopsy every nodule to confirm diag-
nosis. In this pictorial review, we have provided detailed de-
scriptions with corresponding images of sonographic features
of thyroid nodules according to the recent BTA U1–5 classi-
fication. We trust that the ready recognition of benign, suspi-
cious and malignant sonographic features based on the U1–5
classification will assist radiologists and clinicians in the sub-
sequent management of thyroid nodules.
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